To The Moon

Ex-dividend this weekApple $Apple(AAPL)$ Texas Instruments $Texas Instruments(TXN)$ International Business Machines $IBM(IBM)$ Pfizer $Pfizer(PFE)$ Walmart $Wal-Mart(WMT)$ ImageTexas Instruments $Texas Instruments(TXN)$ will pay dividend on MAY7, and current yield is 2.9%.International Business Machines $IBM(IBM)$ ,Pfizer $Pfizer(PFE)$ and Walmart $Wal-Mart(WMT)$ will all pay dividend on MAY9, and PFE current yield is

$AbbVie(ABBV)$ debt (10-Q) Net debt ~$56 B at the end of the quarterNet debt increased ~$9B (ImmunoGen acquisition)$15 B new debt issued (connected to ImmunoGen and proposed Cerevel acquisitions)$9.2 billion acquisition cost of ImmunoGen, Feb12Image$15 B "issued debt in connection with the acquisition of ImmunoGen and proposed acquisition of Cerevel Therapeutics"I had previously "guessed" it would have maturities 2027+ which is now confirmedDetails as follows:Image"The total fair value of the consideration transferred to owners of ImmunoGen common stock was $9.8 billion ($9.2 billion, net of cash acquired)"Cerevel Therapeutics Holdings acquisition expected within 2024, for ~$8.7 BImageABBV Cash FlowSlightly worsening OCF in 1Q49% dividend payoutIm

$Apple(AAPL)$ weak top line; raises dividend by 4%2Q YoYRevenue -4% iPhone -10% ;Services +14% Net Income -2% Dil EPS +1% First 6months OCF flat FCF +4% (lower Capex)New dividend at $0.25/share/quarter (+4%)AAPL apparently IR missed this is Apple´s second quarterImageAAPL segmentsNo Vision Pro breakdownImagea few hours to (a very likely) new dividend levelany guesses?» Another +$0.01/share/Q (keep last 2 hikes trend)?» +$0.02 (+8.3%)» +$0.03 (double digits - First since 2018)» something elseImageAAPL announces a new $110 billion buyback programLast 4 FYs average buyback: $81 billionImagehttps://twitter.com/DividendWave/status/1786134380294873088

1. $Qualcomm(QCOM)$ QCOM 2Q at revenue mid point of guidance; EPS above high end2Q YoYRevenue +1%Net Income +37%Dil. EPS +36% (Adj +13%)OCF +43%FCF +65% (lower Capex)3Q guidance$8.8B - $9.6B in revenue +9% YoY at mid-point2. $Starbucks(SBUX)$ SBUX Cash flow after 2QFCF $4.0 B TTM (up from FY23 at $3.7 B)Capex $2.6 B TTM (up from FY23 at $2.3 B)Dividend payout at 63%ImageSBUX Store count+6% YoY for 2Q (International leading with +9%)This makes the 2% reduction in revenue look even worseImage3. $MasterCard(MA)$ MA 1QYoYRevenue +10%Net income +28%Dil. EPS +30% (Adj. +18%)4. $Novo-Nordisk A/S(NVO)$ Strong 1Q +22% sales (+24% ex

1. $Advanced Micro Devices(AMD)$ AMD 1Q slightly above mid point of revenue guidance1Q YoYRevenue $5.5 B +2% ; -11% QoQ Data center: $2.3 billion (record Q; 80% YoY)Net income +188%Dil. EPS +178% (Adj +2%)2Q outlookRevenue $5.7 billion (6% YoY ; 4% QoQ)AMD record Data center revenue quartermarginally above Q4 last year, but +80% YoYClosing in on $Intel(INTC)$ Image2. $Starbucks(SBUX)$ SBUX ugly 2QYoYRevenue -2% Comp sales -4% (- 6% transactions, +2% average ticket) Net Income -15%Dil. EPS -14%3. $IBM(IBM)$ IBM +0.6% dividend increasefrom $1.66 to $1.67 per share / quarterImage4. $McDon

$Meta Platforms, Inc.(META)$ Cash Flow after 1Q$49.5 B TTM FCF~$27 B TTM Capex (expected at $35-40 B for FY24)First dividend paid in 1Q (~$5 B yearly)At TTM FCF that would be ~10% payoutImageMETA buybacks$112 B since FY19$71.6 B repurchase authorization remains available (~6% of market cap)ImageIt's impressive to see how META is reinvesting in itself with such a substantial buyback. Proves they have confidence in their own growth potential.https://twitter.com/DividendWave/status/1784291553906762090

1. $AbbVie(ABBV)$ ABBV 1Q returns to top line growth 1Q YoYRevenue +0.7% ($12.3 B, above guidance) Humira -36% Skyrizi +48% Rinvoq +59%Net income +473%Dil. EPS +492% (adj -6%) Raises Adj. dil. EPS guidance for FY24 from $10.97 - $11.17 to $11.13 - $11.33ABBV 1Q highlightReturning to revenue growth a year after Humira lost exclusivity in the USHumira in FY22 was the highest selling drug in the worldImage2. $Intel(INTC)$ INTC 1Q Data center-10% (DCAI+Altera combined) YoYImageINTC modified the segment reporting lineDCAI 2023 = in 2024 to (DCAI+Altera)Imagehttps://twitter.com/DividendWave/status/1783825440299204782

1. $Alphabet(GOOG)$ $Alphabet(GOOGL)$ with a strong quarter. Initiates dividend.1Q YoYRevenue +15%Net Income +57%Dil. eps +61%OCF +23%FCF -3% (Capex doubled to $12 B (!)Initiates a $0.20 quarterly dividendApproves new $70 B buyback progrM $Meta Platforms, Inc.(META)$ yesterday: "2024 capital expenditures will be in the range of $35-40 billion"Market reaction: excessiveCapex last 12 months: $Microsoft(MSFT)$ $39.5 billion ($11 B this quarter)GOOG $38.0 billion ($12 B this quarter)Zuckerberg just needs to move the earnings call after these 2.2. $Altria(MO)$ another quarter of doubl

1. $Meta Platforms, Inc.(META)$ strong 1Q YoYRevenue +27% DAP +7%Net income +117%Dil. EPS +114%OCF +37%FCF +79% ($12.8 B)FY guidanceRevenue "$96-99 B, prior outlook of $94-99 B"Capex "in the range of $35-40 billion, increased from our prior range of $30-37 billion"2. $Lam Research(LRCX)$ 3Q as guided, guides for a flat QoQ Revenue3Q YoY Revenue +0.9% QoQ -2%YoY China 42% of revenueNet income +19%Dil. EPS +22%OCF -20%FCF -20%4Q guidance$3.8 B revenue flat QoQ +18% YoY3. $Humana(HUM)$ 1Q revises down FY guidance1Q YoYRevenue +11%Net Income -40%Dil. EPS -38% (Adj -23%)OCF -96% (CMS early payment in 23)FCF -98%"Revises FY24 EPS guidance to 'approx $13.93' (previously

$Texas Instruments(TXN)$ Cash Flow after 1QTTM FCF $0.9 B (Last FY below $1 B was 2001)Dividends 5x that ($4.6 B)Capex $5.3 (above guided per year for 2023-2026 )ImageTXN balance sheet showing (debt) the effort to pay dividends while keeping this elevated Capex ImageTXN Capex guidance $5 B / yearImageTXN 2001 FCF below $1 B (negative the year before)ImageTXN weak quarter, revenue mid point of guidance1Q YoY Revenue -16% // -10% QoQ Net Income -35% Dil. EPS -35% OCF -12% FCF negative 2Q outlook Revenue $3.65 billion to $3.95 billion (-16% YoY at mid point ; +4% QoQ)Image